Mechanosensitive PPAP2B Regulates Endothelial Responses to Atherorelevant Hemodynamic Forces. Issue 4 (31st July 2015)

• Record Type: Journal Article
• Authors: Wu, Congqing; Huang, Ru-Ting; Kuo, Cheng-Hsiang; Kumar, Sandeep; Woo Kim, Chan; Lin, Yen-Chen; Chen, Yen-Ju; Birukova, Anna; Birukov, Konstantin G.; Dulin, Nickolai O.; Civelek, Mete; Lusis, Aldons J.; Loyer, Xavier; Tedgui, Alain; Dai, Guohao; Jo, Hanjoong; Fang, Yun
• Is Part Of: Circulation research. Volume 117:Issue 4(2015)
• Publication Date: 2015-07-31
• Subjects: Cardiovascular system -- Periodicals; Blood -- Circulation -- Periodicals; Blood Circulation; Cardiovascular System; Vascular Diseases; Sang -- Circulation -- Périodiques; Appareil cardiovasculaire -- Périodiques; 612.1
• DOI: 10.1161/CIRCRESAHA.117.306457
• Languages: English
• ISSNs: 0009-7330

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title> <underline>Rationale:</underline> </title> <p>PhosPhatidic Acid Phosphatase type 2B (PPAP2B), an integral membrane protein known as lipid phosphate phosphatase (LPP3) that inactivates lysophosphatidic acid, was implicated in coronary artery disease (CAD) by genome-wide association studies. However, it is unclear whether genome-wide association studies–identified coronary artery disease genes, including <italic>PPAP2B</italic>, participate in mechanotransduction mechanisms by which vascular endothelia respond to local atherorelevant hemodynamics that contribute to the regional nature of atherosclerosis.</p> </sec> <sec> <title> <underline>Objective:</underline> </title> <p>To establish the critical role of PPAP2B in endothelial responses to hemodynamics.</p> </sec> <sec> <title> <underline>Methods and Results:</underline> </title> <p>Reduced PPAP2B was detected in vivo in mouse and swine aortic arch (AA) endothelia exposed to chronic disturbed flow, and in mouse carotid artery endothelia subjected to surgically induced acute disturbed flow. In humans, <italic>PPAP2B</italic> was reduced in the downstream part of carotid plaques where low shear stress prevails. In culture, reduced PPAP2B was measured in human aortic endothelial cells under atherosusceptible waveform mimicking flow in human carotid sinus. Flow-sensitive microRNA-92a and transcription factor KLF2 were identified as upstream inhibitor and activator of endothelial <italic>PPAP2B</italic>, respectively. PPAP2B suppression abrogated atheroprotection of unidirectional flow; inhibition of lysophosphatidic acid receptor 1 restored the flow-dependent, anti-inflammatory phenotype in PPAP2B-deficient cells. PPAP2B inhibition resulted in myosin light-chain phosphorylation and intercellular gaps, which were abolished by lysophosphatidic acid receptor 1/2 inhibition. Expression quantitative trait locus mapping demonstrated <italic>PPAP2B</italic> coronary artery disease risk allele is not linked to <italic>PPAP2B</italic> expression in various human tissues but significantly associated with reduced <italic>PPAP2B</italic> in human aortic endothelial cells.</p> </sec> <sec> <title> <underline>Conclusions:</underline> </title> <p>Atherorelevant flows dynamically modulate endothelial PPAP2B expression through miR-92a and KLF2. Mechanosensitive PPAP2B plays a critical role in promoting anti-inflammatory phenotype and maintaining vascular integrity of endothelial monolayer under atheroprotective flow.</p> </sec> </abstract>